The role of the neuropeptide S system in addiction: Focus on its interaction with the CRF and hypocretin/orexin neurotransmission

Progress in Neurobiology

Volumn 100, Issue 1, 2013, Pages 48-59

  Cannella, Nazzareno ^a,b   Kallupi, Marsida ^a,c   Ruggeri, Barbara ^a   Ciccocioppo, Roberto ^a   Ubaldi, Massimo ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Addiction; Alcohol; Cocaine; NPS; NPSR; Reinstatement; Reward; Self administration

Indexed keywords

3 OXO 1,1 DIPHENYLTETRAHYDRO OXAZOLO[3,4 A]PYRAZINE 7 CARBOXYLIC ACID 4 FLUORO BENZYLAMIDE; AMPHETAMINE; CAFFEINE; COCAINE; CORTICOTROPIN RELEASING FACTOR; MORPHINE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S; NEUROPEPTIDE S RECEPTOR ANTAGONIST; OREXIN; OREXIN A; PEPTIDE HORMONE RECEPTOR BLOCKING AGENT; SHA 68; UNCLASSIFIED DRUG;

ADDICTION; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; BRAIN REGION; HUMAN; NEUROANATOMY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; REWARD; SUBSTANCE ABUSE;

ANIMALS; CONDITIONING, OPERANT; CORTICOTROPIN-RELEASING HORMONE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; REWARD; SUBSTANCE-RELATED DISORDERS; SYNAPTIC TRANSMISSION;

EID: 84870932060     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2012.09.005     Document Type: Review

References (124)

1. Al-Barazanji K.A., Wilson S., Baker J., Jessop D.S., Harbuz M.S. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. Journal of Neuroendocrinology 2001, 13:421-424.
2. Badia-Elder N.E., Henderson A.N., Bertholomey M.L., Dodge N.C., Stewart R.B. The effects of neuropeptide S on ethanol drinking and other related behaviors in alcohol-preferring and -nonpreferring rats. Alcoholism, Clinical and Experimental Research 2008, 32:1380-1387.
3. Balcita-Pedicino J.J., Sesack S.R. Orexin axons in the rat ventral tegmental area synapse infrequently onto dopamine and gamma-aminobutyric acid neurons. Journal of Comparative Neurology 2007, 503:668-684.
4. Beck B., Fernette B., Stricker-Krongrad A. Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats. Biochemical and Biophysical Research Communications 2005, 332:859-865.
5. Boeck C.R., Martinello C., de Castro A.A., Moretti M., Dos Santos Casagrande T., Guerrini R., Calo G., Gavioli E.C. Blockade of adenosine A2A receptor counteracts neuropeptide-S-induced hyperlocomotion in mice. Naunyn-Schmiedebergs Archives of Pharmacology 2010, 381:153-160.
6. Bokstrom K., Balldin J., Langstrom G. Individual mood profiles in alcohol withdrawal. Alcoholism, Clinical and Experimental Research 1991, 15:508-513.
7. Borgland S.L., Chang S.J., Bowers M.S., Thompson J.L., Vittoz N., Floresco S.B., Chou J., Chen B.T., Bonci A. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. Journal of Neuroscience 2009, 29:11215-11225.
8. Bouret S., Sara S.J. Reward expectation, orientation of attention and locus coeruleus-medial frontal cortex interplay during learning. European Journal of Neuroscience 2004, 20:791-802.
9. Bouret S., Sara S.J. Network reset: a simplified overarching theory of locus coeruleus noradrenaline function. Trends in Neurosciences 2005, 28:574-582.
10. Brown R.M., Short J.L. Adenosine A(2A) receptors and their role in drug addiction. Journal of Pharmacy and Pharmacology 2008, 60:1409-1430.
11. Buffalari D.M., See R.E. Inactivation of the bed nucleus of the stria terminalis in an animal model of relapse: effects on conditioned cue-induced reinstatement and its enhancement by yohimbine. Psychopharmacology 2011, 213:19-27.
12. Camarda V., Rizzi A., Ruzza C., Zucchini S., Marzola G., Marzola E., Guerrini R., Salvadori S., Reinscheid R.K., Regoli D., Calo G. In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S. Journal of Pharmacology and Experimental Therapeutics 2009, 328:549-555.
13. Cannella N., Economidou D., Kallupi M., Stopponi S., Heilig M., Massi M., Ciccocioppo R. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology 2009, 34:2125-2134.
14. Cannella N., Ruggeri B., Kallupi M., Li H.W., Ubaldi M., Soverchia L., Ciccocioppo R. Blockade of hypocretin-1/orexin-A receptors prevent neuropeptide S-induced potentiation of relapse elicited by alcohol cues: a neurocircuitry study. A.C.E.R. Supplement 2010, 34(8):P010.
15. Cannella N., Ruggeri B., Ubaldi M., Braconi S., Kallupi M., Massi M., Ciccocioppo R. Neuropeptide S differently modulate ethanol self-administration and cue-induced reinstatement of ethanol seeking in msP and wistar rats. Behavioral Pharmacology Special Issue 2009, 1:S31P30.
16. Cao J., de Lecea L., Ikemoto S. Intraventricular administration of neuropeptide S has reward-like effects. European Journal of Pharmacology 2011, 658:16-21.
17. Castro A.A., Moretti M., Casagrande T.S., Martinello C., Petronilho F., Steckert A.V., Guerrini R., Calo G., Dal Pizzol F., Quevedo J., Gavioli E.C. Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam. Pharmacology, Biochemistry and Behavior 2009, 91:636-642.
18. Chen M.F., Chiu T.H., Lee E.H. Noradrenergic mediation of the memory-enhancing effect of corticotropin-releasing factor in the locus coeruleus of rats. Psychoneuroendocrinology 1992, 17:113-124.
19. Ciccocioppo R., Angeletti S., Weiss F. Long-lasting resistance to extinction of response reinstatement induced by ethanol-related stimuli: role of genetic ethanol preference. Alcoholism, Clinical and Experimental Research 2001, 25:1414-1419.
20. Ciccocioppo R., Economidou D., Cippitelli A., Cucculelli M., Ubaldi M., Soverchia L., Lourdusamy A., Massi M. Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addiction Biology 2006, 11:339-355.
21. Cifani C., Micioni Di Bonaventura M.V., Cannella N., Fedeli A., Guerrini R., Calo G., Ciccocioppo R., Ubaldi M. Effect of neuropeptide S receptor antagonists and partial agonists on palatable food consumption in the rat. Peptides 2011, 32:44-50.
22. Damasio A.R. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 1996, 351:1413-1420.
23. Dayas C.V., McGranahan T.M., Martin-Fardon R., Weiss F. Stimuli linked to ethanol availability activate hypothalamic CART and orexin neurons in a reinstatement model of relapse. Biological Psychiatry 2008, 63:152-157.
24. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug and Alcohol Dependence 1995, 38:95-137.
25. Domschke K., Reif A., Weber H., Richter J., Hohoff C., Ohrmann P., Pedersen A., Bauer J., Suslow T., Kugel H., Heindel W., Baumann C., Klauke B., Jacob C., Maier W., Fritze J., Bandelow B., Krakowitzky P., Rothermundt M., Erhardt A., Binder E.B., Holsboer F., Gerlach A.L., Kircher T., Lang T., Alpers G.W., Strohle A., Fehm L., Gloster A.T., Wittchen H.U., Arolt V., Pauli P., Hamm A., Deckert J. Neuropeptide S receptor gene - converging evidence for a role in panic disorder. Molecular Psychiatry 2011, 16:938-948.
26. Duangdao D.M., Clark S.D., Okamura N., Reinscheid R.K. Behavioral phenotyping of neuropeptide S receptor knockout mice. Behavioural Brain Research 2009, 205:1-9.
27. Erb S., Stewart J. A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. Journal of Neuroscience 1999, 19:RC35.
28. Espana R.A., Melchior J.R., Roberts D.C., Jones S.R. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology 2011, 214:415-426.
29. Espana R.A., Reis K.M., Valentino R.J., Berridge C.W. Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. Journal of Comparative Neurology 2005, 481:160-178.
30. Fedeli A., Braconi S., Economidou D., Cannella N., Kallupi M., Guerrini R., Calo G., Cifani C., Massi M., Ciccocioppo R. The paraventricular nucleus of the hypothalamus is a neuroanatomical substrate for the inhibition of palatable food intake by neuropeptide S. European Journal of Neuroscience 2009, 30:1594-1602.
31. Fendt M., Buchi M., Burki H., Imobersteg S., Ricoux B., Suply T., Sailer A.W. Neuropeptide S receptor deficiency modulates spontaneous locomotor activity and the acoustic startle response. Behavioural Brain Research 2011, 217:1-9.
32. Gonzales R.A., Job M.O., Doyon W.M. The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacology and Therapeutics 2004, 103:121-146.
33. Guerrini R., Camarda V., Trapella C., Calo G., Rizzi A., Ruzza C., Fiorini S., Marzola E., Reinscheid R.K., Regoli D., Salvadori S. Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. Journal of Medicinal Chemistry 2009, 52:4068-4071.
34. Hack S.P., Christie M.J. Adaptations in adenosine signaling in drug dependence: therapeutic implications. Critical Reviews in Neurobiology 2003, 15:235-274.
35. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P., Munton R.P., Ashmeade T.E., Shah A.S., Hatcher J.P., Hatcher P.D., Jones D.N., Smith M.I., Piper D.C., Hunter A.J., Porter R.A., Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:10911-10916.
36. Hamlin A.S., Clemens K.J., McNally G.P. Renewal of extinguished cocaine-seeking. Neuroscience 2008, 151:659-670.
37. Han R.W., Yin X.Q., Chang M., Peng Y.L., Li W., Wang R. Neuropeptide S facilitates spatial memory and mitigates spatial memory impairment induced by N-methyl-d-aspartate receptor antagonist in mice. Neuroscience Letters 2009, 455:74-77.
38. Hansson A.C., Cippitelli A., Sommer W.H., Fedeli A., Bjork K., Soverchia L., Terasmaa A., Massi M., Heilig M., Ciccocioppo R. Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:15236-15241.
39. Hata T., Chen J., Ebihara K., Date Y., Ishida Y., Nakahara D. Intra-ventral tegmental area or intracerebroventricular orexin-A increases the intra-cranial self-stimulation threshold via activation of the corticotropin-releasing factor system in rats. European Journal of Neuroscience 2011, 34:816-826.
40. Hervieu G.J., Cluderay J.E., Harrison D.C., Roberts J.C., Leslie R.A. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001, 103:777-797.
41. Horvath T.L., Peyron C., Diano S., Ivanov A., Aston-Jones G., Kilduff T.S., van Den Pol A.N. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. Journal of Comparative Neurology 1999, 415:145-159.
42. Hyman S.E., Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nature Reviews Neuroscience 2001, 2:695-703.
43. Introini-Collison I., Saghafi D., Novack G.D., McGaugh J.L. Memory-enhancing effects of post-training dipivefrin and epinephrine: involvement of peripheral and central adrenergic receptors. Brain Research 1992, 572:81-86.
44. James M.H., Charnley J.L., Levi E.M., Jones E., Yeoh J.W., Smith D.W., Dayas C.V. Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking. International Journal of Neuropsychopharmacology 2011, 14:684-690.
45. Jungling K., Liu X., Lesting J., Coulon P., Sosulina L., Reinscheid R.K., Pape H.C. Activation of neuropeptide S-expressing neurons in the locus coeruleus by corticotropin-releasing factor. Journal of Physiology 2012, 590:3701-3717.
46. Jungling K., Seidenbecher T., Sosulina L., Lesting J., Sangha S., Clark S.D., Okamura N., Duangdao D.M., Xu Y.-L., Reinscheid R.K., Pape H.-C. Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron 2008, 59:298-310.
47. Kallupi M., Cannella N., Economidou D., Ubaldi M., Ruggeri B., Weiss F., Massi M., Marugan J., Heilig M., Bonnavion P., de Lecea L., Ciccocioppo R. Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:19567-19572.
48. Kallupi M., de Guglielmo G., Cannella N., Li H.W., Calò G., Ubaldi M., Renger J.J., Uebele V.N., Ciccocioppo R. Hypothalamic neuropeptide S receptor blockade abolishes cue-induced reinstatement of cocaine seeking in the rat. Psychopharmacology 2012, 10.1007/s00213-012-2910-y.
49. Koob G.F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56(Suppl. 1):18-31.
50. Lage R., Dieguez C., Lopez M. Caffeine treatment regulates neuropeptide S system expression in the rat brain. Neuroscience Letters 2006, 410:47-51.
51. Lage R., Gonzalez C.R., Dieguez C., Lopez M. Nicotine treatment regulates neuropeptide S system expression in the rat brain. Neurotoxicology 2007, 28:1129-1135.
52. Laitinen T., Polvi A., Rydman P., Vendelin J., Pulkkinen V., Salmikangas P., Makela S., Rehn M., Pirskanen A., Rautanen A., Zucchelli M., Gullsten H., Leino M., Alenius H., Petays T., Haahtela T., Laitinen A., Laprise C., Hudson T.J., Laitinen L.A., Kere J. Characterization of a common susceptibility locus for asthma-related traits. Science 2004, 304:300-304.
53. Lawrence A.J., Cowen M.S., Yang H.-J., Chen F., Oldfield B. The orexin system regulates alcohol-seeking in rats. British Journal of Pharmacology 2006, 148:752-759.
54. Le A., Shaham Y. Neurobiology of relapse to alcohol in rats. Pharmacology and Therapeutics 2002, 94:137-156.
55. Leonard S.K., Dwyer J.M., Sukoff Rizzo S.J., Platt B., Logue S.F., Neal S.J., Malberg J.E., Beyer C.E., Schechter L.E., Rosenzweig-Lipson S., Ring R.H. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology 2008, 197:601-611.
56. Leonard S.K., Ring R.H. Immunohistochemical localization of the neuropeptide S receptor in the rat central nervous system. Neuroscience 2011, 172:153-163.
57. Lerner T.N., Horne E.A., Stella N., Kreitzer A.C. Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists. Journal of Neuroscience 2010, 30:2160-2164.
58. Li W., Gao Y.H., Chang M., Peng Y.L., Yao J., Han R.W., Wang R. Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice. Peptides 2009, 30:234-240.
59. Liu X., Zeng J., Zhou A., Theodorsson E., Fahrenkrug J., Reinscheid R.K. Molecular fingerprint of neuropeptide S-producing neurons in the mouse brain. Journal of Comparative Neurology 2011, 519:1847-1866.
60. Lucantonio F., Stalnaker T.A., Shaham Y., Niv Y., Schoenbaum G. The impact of orbitofrontal dysfunction on cocaine addiction. Nature Neuroscience 2012, 15:358-366.
61. Lukas M., Neumann I.D. Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: social versus non-social effects. Neuropharmacology 2012, 62:398-405.
62. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. Journal of Comparative Neurology 2001, 435:6-25.
63. Martire A., Tebano M.T., Chiodi V., Ferreira S.G., Cunha R.A., Kofalvi A., Popoli P. Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission. Journal of Neurochemistry 2011, 116:273-280.
64. McGaugh J.L. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annual Review of Neuroscience 2004, 27:1-28.
65. Meis S., Bergado-Acosta J.R., Yanagawa Y., Obata K., Stork O., Munsch T. Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform nucleus. PLoS ONE 2008, 3(7):e2695.
66. Melamed J.Y., Zartman A.E., Kett N.R., Gotter A.L., Uebele V.N., Reiss D.R., Condra C.L., Fandozzi C., Lubbers L.S., Rowe B.A., McGaughey G.B., Henault M., Stocco R., Renger J.J., Hartman G.D., Bilodeau M.T., Trotter B.W. Synthesis and evaluation of a new series of neuropeptide S receptor antagonists. Bioorganic and Medicinal Chemistry Letters 2010, 20:4700-4703.
67. Micioni Di Bonaventura M.V., Cifani C., Lambertucci C., Volpini R., Cristalli G., Froldi R., Massi M. Effects of AA adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats. Psychopharmacology 2012, 219:945-957.
68. Mochizuki T., Kim J., Sasaki K. Microinjection of neuropeptide S into the rat ventral tegmental area induces hyperactivity and increases extracellular levels of dopamine metabolites in the nucleus accumbens shell. Peptides 2010, 31:926-931.
69. Moorman D.E., Aston-Jones G. Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol-preferring Sprague-Dawley rats. Alcohol 2009, 43:379-386.
70. Niimi M. Centrally administered neuropeptide S activates orexin-containing neurons in the hypothalamus and stimulates feeding in rats. Endocrine 2006, 30:75-79.
71. O'Brien C.P., Childress A.R., Ehrman R., Robbins S.J. Conditioning factors in drug abuse: can they explain compulsion?. Journal of Psychopharmacology 1998, 12:15-22.
72. Ohmura Y., Yamaguchi T., Futami Y., Togashi H., Izumi T., Matsumoto M., Yoshida T., Yoshioka M. Corticotropin releasing factor enhances attentional function as assessed by the five-choice serial reaction time task in rats. Behavioural Brain Research 2009, 198:429-433.
73. Okamura N., Garau C., Duangdao D.M., Clark S.D., Jungling K., Pape H.C., Reinscheid R.K. Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain. Neuropsychopharmacology 2011, 36:744-752.
74. Okamura N., Habay S.A., Zeng J., Chamberlin A.R., Reinscheid R.K. Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor. Journal of Pharmacology and Experimental Therapeutics 2008, 325:893-901.
75. Okamura N., Hashimoto K., Iyo M., Shimizu E., Dempfle A., Friedel S., Reinscheid R.K. Gender-specific association of a functional coding polymorphism in the neuropeptide S receptor gene with panic disorder but not with schizophrenia or attention-deficit/hyperactivity disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007, 31:1444-1448.
76. Okamura N., Reinscheid R.K., Ohgake S., Iyo M., Hashimoto K. Neuropeptide S attenuates neuropathological, neurochemical and behavioral changes induced by the NMDA receptor antagonist MK-801. Neuropharmacology 2010, 58:166-172.
77. Paneda C., Huitron-Resendiz S., Frago L.M., Chowen J.A., Picetti R., de Lecea L., Roberts A.J. Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice. Journal of Neuroscience 2009, 29:4155-4161.
78. Peng Y.-L., Han R.-W., Chang M., Zhang L., Zhang R.-S., Li W., Han Y.-F., Wang R. Central neuropeptide S inhibits food intake in mice through activation of neuropeptide S receptor. Peptides 2010, 31:2259-2263.
79. Plaza-Zabala A., Martin-Garcia E., de Lecea L., Maldonado R., Berrendero F. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. Journal of Neuroscience 2010, 30:2300-2310.
80. Pulkkinen V., Haataja R., Hannelius U., Helve O., Pitkanen O.M., Karikoski R., Rehn M., Marttila R., Lindgren C.M., Hastbacka J., Andersson S., Kere J., Hallman M., Laitinen T. G protein-coupled receptor for asthma susceptibility associates with respiratory distress syndrome. Annals of Medicine 2006, 38:357-366.
81. Quirarte G.L., Roozendaal B., McGaugh J.L. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:14048-14053.
82. Raiteri L., Luccini E., Romei C., Salvadori S., Calo G. Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings. British Journal of Pharmacology 2009, 157:474-481.
83. Rasmussen D.D., Boldt B.M., Bryant C.A., Mitton D.R., Larsen S.A., Wilkinson C.W. Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcoholism, Clinical and Experimental Research 2000, 24:1836-1849.
84. Rasmussen K., Jacobs B.L. Single unit activity of locus coeruleus neurons in the freely moving cat, II. Conditioning and pharmacologic studies. Brain Research 1986, 371:335-344.
85. Reinscheid R.K. Phylogenetic appearance of neuropeptide S precursor proteins in tetrapods. Peptides 2007, 28:830-837.
86. Reinscheid R.K., Xu Y.-L. Neuropeptide S and its receptor: a newly deorphanized G protein-coupled receptor system. Neuroscientist 2005, 11:532-538.
87. Reinscheid R.K., Xu Y.L., Okamura N., Zeng J., Chung S., Pai R., Wang Z., Civelli O. Pharmacological characterization of human and murine neuropeptide s receptor variants. Journal of Pharmacology and Experimental Therapeutics 2005, 315:1338-1345.
88. Richards J.K., Simms J.A., Steensland P., Taha S.A., Borgland S.L., Bonci A., Bartlett S.E. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology 2008, 199:109-117.
89. Rizzi A., Vergura R., Marzola G., Ruzza C., Guerrini R., Salvadori S., Regoli D., Calo G. Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. British Journal of Pharmacology 2008, 154:471-479.
90. Rodaros D., Caruana D.A., Amir S., Stewart J. Corticotropin-releasing factor projections from limbic forebrain and paraventricular nucleus of the hypothalamus to the region of the ventral tegmental area. Neuroscience 2007, 150:8-13.
91. Roelofs S.M. Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome. Alcohol 1985, 2:501-505.
92. Roelofs S.M., Dikkenberg G.M. Hyperventilation and anxiety: alcohol withdrawal symptoms decreasing with prolonged abstinence. Alcohol 1987, 4:215-220.
93. Roth A.L., Marzola E., Rizzi A., Arduin M., Trapella C., Corti C., Vergura R., Martinelli P., Salvadori S., Regoli D., Corsi M., Cavanni P., Calo G., Guerrini R. Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation. Journal of Biological Chemistry 2006, 281:20809-20816.
94. Ruggeri B., Braconi S., Cannella N., Kallupi M., Soverchia L., Ciccocioppo R., Ubaldi M. Neuropeptide S receptor gene expression in alcohol withdrawal and protracted abstinence in postdependent rats. Alcoholism, Clinical and Experimental Research 2010, 34:90-97.
95. Ruzza C., Pulga A., Rizzi A., Marzola G., Guerrini R., Calo G. Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor. Neuropharmacology 2012, 62:1999-2009.
96. Ruzza C., Rizzi A., Trapella C., Pela M., Camarda V., Ruggieri V., Filaferro M., Cifani C., Reinscheid R.K., Vitale G., Ciccocioppo R., Salvadori S., Guerrini R., Calo G. Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. Peptides 2010, 31:915-925.
97. Sakamoto F., Yamada S., Ueta Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regulatory Peptides 2004, 118:183-191.
98. Sarnyai Z., Shaham Y., Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacological Reviews 2001, 53:209-243.
99. Schneider E.R., Rada P., Darby R.D., Leibowitz S.F., Hoebel B.G. Orexigenic peptides and alcohol intake: differential effects of orexin, galanin, and ghrelin. Alcoholism, Clinical and Experimental Research 2007, 31:1858-1865.
100. Shalev U., Grimm J.W., Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacological Reviews 2002, 54:1-42.
101. Si W., Aluisio L., Okamura N., Clark S.D., Fraser I., Sutton S.W., Bonaventure P., Reinscheid R.K. Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex. Journal of Neurochemistry 2010, 115:475-482.
102. Sinha R., Fox H.C., Hong K.I., Hansen J., Tuit K., Kreek M.J. Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Archives of General Psychiatry 2011, 68:942-952.
103. Sinha R., Fuse T., Aubin L.R., O'Malley S.S. Psychological stress, drug-related cues and cocaine craving. Psychopharmacology 2000, 152:140-148.
104. Sinha R., Li C.S.R. Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug and Alcohol Review 2007, 26:25-31.
105. Smith K.L., Patterson M., Dhillo W.S., Patel S.R., Semjonous N.M., Gardiner J.V., Ghatei M.A., Bloom S.R. Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology 2006, 147:3510-3518.
106. Snyder K., Wang W.W., Han R., McFadden K., Valentino R.J. Corticotropin-releasing factor in the norepinephrine nucleus, locus coeruleus, facilitates behavioral flexibility. Neuropsychopharmacology 2012, 37:520-530.
107. Spanagel R., Weiss F. The dopamine hypothesis of reward: past and current status. Trends in Neurosciences 1999, 22:521-527.
108. Stewart R.B., Gatto G.J., Lumeng L., Li T.K., Murphy J.M. Comparison of alcohol-preferring (P) and nonpreferring (NP) rats on tests of anxiety and for the anxiolytic effects of ethanol. Alcohol 1993, 10:1-10.
109. Tancredi T., Guerrini R., Marzola E., Trapella C., Calo G., Regoli D., Reinscheid R.K., Camarda V., Salvadori S., Temussi P.A. Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor. Journal of Medicinal Chemistry 2007, 50:4501-4508.
110. Trotter B.W., Nanda K.K., Manley P.J., Uebele V.N., Condra C.L., Gotter A.L., Menzel K., Henault M., Stocco R., Renger J.J., Hartman G.D., Bilodeau M.T. Tricyclic imidazole antagonists of the neuropeptide S receptor. Bioorganic and Medicinal Chemistry Letters 2010, 20:4704-4708.
111. Vendelin J., Pulkkinen V., Rehn M., Pirskanen A., Raisanen-Sokolowski A., Laitinen A., Laitinen L.A., Kere J., Laitinen T. Characterization of GPRA, a novel G protein-coupled receptor related to asthma. American Journal of Respiratory Cell and Molecular Biology 2005, 33:262-270.
112. Verdejo-Garcia A., Bechara A. A somatic marker theory of addiction. Neuropharmacology 2009, 56(Suppl. 1):48-62.
113. Vitale G., Filaferro M., Ruggieri V., Pennella S., Frigeri C., Rizzi A., Guerrini R., Calo G. Anxiolytic-like effect of neuropeptide S in the rat defensive burying. Peptides 2008, 29:2286-2291.
114. Wang B., You Z.B., Wise R.A. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biological Psychiatry 2009, 65:857-862.
115. Wegener G., Finger B.C., Elfving B., Keller K., Liebenberg N., Fischer C.W., Singewald N., Slattery D.A., Neumann I.D., Mathe A.A. Neuropeptide S alters anxiety, but not depression-like behaviour in Flinders Sensitive Line rats: a genetic animal model of depression. International Journal of Neuropsychopharmacology 2011, 15:375-387.
116. Weiss F., Ciccocioppo R., Parsons L.H., Katner S., Liu X., Zorrilla E.P., Valdez G.R., Ben-Shahar O., Angeletti S., Richter R.R. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Annals of the New York Academy of Sciences 2001, 937:1-26.
117. Willinger U., Lenzinger E., Hornik K., Fischer G., Schonbeck G., Aschauer H.N., Meszaros K. Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Alcohol and Alcoholism 2002, 37:609-612.
118. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., Kilduff T.S., Horvath T.L., de Lecea L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. Journal of Neuroscience 2004, 24:11439-11448.
119. Xu Y.-L., Gall C.M., Jackson V.R., Civelli O., Reinscheid R.K. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. Journal of Comparative Neurology 2007, 500:84-8102.
120. Xu Y.-L., Reinscheid R.K., Huitron-Resendiz S., Clark S.D., Wang Z., Lin S.H., Brucher F.A., Zeng J., Ly N.K., Henriksen S.J., de Lecea L., Civelli O. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 2004, 43:487-497.
121. Yoshida K., Kim J., Nakajima K., Oomura Y., Wayner M.J., Sasaki K. Electrophysiological effects of neuropeptide S on rat ventromedial hypothalamic neurons in vitro. Peptides 2010, 31:712-719.
122. Zhang Y., Gilmour B.P., Navarro H.A., Runyon S.P. Identifying structural features on 1,1-diphenyl-hexahydro-oxazolo[3,4-a]pyrazin-3-ones critical for neuropeptide S antagonist activity. Bioorganic and Medicinal Chemistry Letters 2008, 18:4064-4067.
123. Zhu H., Mingler M.K., McBride M.L., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Williams M.T., Vorhees C.V., Rothenberg M.E. Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1. Psychoneuroendocrinology 2010, 35:1119-1132.
124. Zorrilla E.P., Valdez G.R., Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology 2001, 158:374-381.